- Home
- ZOM vs OPRX Comparison
ZOM vs OPRX Comparison
Compare ZOM & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOM
- OPRX
- Stock Information
- Founded
- ZOM 2015
- OPRX 2006
- Country
- ZOM United States
- OPRX United States
- Employees
- ZOM N/A
- OPRX N/A
- Industry
- ZOM Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- ZOM Health Care
- OPRX Consumer Discretionary
- Exchange
- ZOM Nasdaq
- OPRX Nasdaq
- Market Cap
- ZOM 135.9M
- OPRX 111.2M
- IPO Year
- ZOM N/A
- OPRX N/A
- Fundamental
- Price
- ZOM $0.13
- OPRX $4.87
- Analyst Decision
- ZOM
- OPRX Strong Buy
- Analyst Count
- ZOM 0
- OPRX 5
- Target Price
- ZOM N/A
- OPRX $8.80
- AVG Volume (30 Days)
- ZOM 7.3M
- OPRX 377.6K
- Earning Date
- ZOM 11-07-2024
- OPRX 11-13-2024
- Dividend Yield
- ZOM N/A
- OPRX N/A
- EPS Growth
- ZOM N/A
- OPRX N/A
- EPS
- ZOM N/A
- OPRX N/A
- Revenue
- ZOM $26,727,000.00
- OPRX $88,179,506.00
- Revenue This Year
- ZOM $36.75
- OPRX $43.61
- Revenue Next Year
- ZOM $14.92
- OPRX $12.92
- P/E Ratio
- ZOM N/A
- OPRX N/A
- Revenue Growth
- ZOM 11.33
- OPRX 40.40
- 52 Week Low
- ZOM $0.12
- OPRX $3.78
- 52 Week High
- ZOM $0.23
- OPRX $16.65
- Technical
- Relative Strength Index (RSI)
- ZOM 51.79
- OPRX 43.50
- Support Level
- ZOM $0.12
- OPRX $3.78
- Resistance Level
- ZOM $0.16
- OPRX $4.53
- Average True Range (ATR)
- ZOM 0.01
- OPRX 0.56
- MACD
- ZOM 0.00
- OPRX -0.03
- Stochastic Oscillator
- ZOM 33.95
- OPRX 35.50
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.